Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
its not yet prescribable through legitimate compounding pharmacies
feedback preserved Sustained elevation
Formulated to support healthy skin, immune function, and overall wellbeing, this advanced blend works from within to help neutralise free radicals and maintain the bodys natural detoxification processes
Research institution pipeline expansion
Animal studies have provided evidence that sitagliptin and linagliptin exhibit the ability to attenuate the activity of NLRP3/inflammasome (198)
Untreated Controls Preclinical injury models % reduction in healing time Tendon Transection (Rat Achilles model)50% Skin Wound Closure (Alkali burn model)45% Muscle Crush Injury (Rat quadriceps)40% Safety Data Safety Profile from Research What preclinical and early clinical studies report Preclinical Safety Summary LD50Not achieved Acute toxicityNone observed Chronic toxicityNone in 6-month studies Organ toxicityNone detected Human IV pilot (n=2)No adverse effects Cardiac/hepatic/renalNo effects detected Regulatory & Risk Considerations FDA statusUnapproved drug WADA statusBanned since 2022 (S0) Human trialsPhase 1 only Long-term effectsUnknown in humans Pro-angiogenic riskTheoretical unstudied Australia/NZPrescription only No lethal dose was reached in preclinical toxicology studies
US$ 27.89
US$ 25.05
